Abstract
Earlier this year our dear friend and colleague Professor Tony Dodi died suddenly. He was a Scientist of immense integrity and worked with many of the authors who have contributed to the current series of articles focussing on Cancer Biomarkers. His laboratory at Nottingham Trent University (NTU) authored the article entitled “NK Cells, monocytes and Non T-cell biomarkers as prognostic indicators in cancer immunotherapy” in issue 1 and he contributed enormously to the progress and wellbeing of the ENACT Research programme funded by the EU under FP6. During his career, Tony worked with Robert Lachler and Richard Bachelor at The Royal Postgraduate Medical School, Hammersmith London, prior to joining Professor Alejandro Madrigal at the Anthony Nolan Research Institute. In 2005, Tony was appointed as Professor of Haemato-oncology and Head of Leukaemia Research at NTU. He also continued to head the Immunotherapy Group at the Anthony Nolan Research Institute in London. His legacy exists in the research he undertook in the field of Cancer Immunotherapy and Transplantation Immunology and he was recently involved in the development of the Anthony Nolan Cord Blood Programme, which was developed as a result of his enthusiasm and energy. From the outset, I admired his research ability and determination and consider it to be a distinct privilege as well as pleasure to have known Tony as a colleague and close friend. He is sorely missed by all who knew him and we wish to dedicate this series of papers to his memory. We will not forget Tonys contribution to our research endeavours.
Current Cancer Therapy Reviews
Title: Dedication to Professor Tony Dodi
Volume: 4 Issue: 2
Abstract: Earlier this year our dear friend and colleague Professor Tony Dodi died suddenly. He was a Scientist of immense integrity and worked with many of the authors who have contributed to the current series of articles focussing on Cancer Biomarkers. His laboratory at Nottingham Trent University (NTU) authored the article entitled “NK Cells, monocytes and Non T-cell biomarkers as prognostic indicators in cancer immunotherapy” in issue 1 and he contributed enormously to the progress and wellbeing of the ENACT Research programme funded by the EU under FP6. During his career, Tony worked with Robert Lachler and Richard Bachelor at The Royal Postgraduate Medical School, Hammersmith London, prior to joining Professor Alejandro Madrigal at the Anthony Nolan Research Institute. In 2005, Tony was appointed as Professor of Haemato-oncology and Head of Leukaemia Research at NTU. He also continued to head the Immunotherapy Group at the Anthony Nolan Research Institute in London. His legacy exists in the research he undertook in the field of Cancer Immunotherapy and Transplantation Immunology and he was recently involved in the development of the Anthony Nolan Cord Blood Programme, which was developed as a result of his enthusiasm and energy. From the outset, I admired his research ability and determination and consider it to be a distinct privilege as well as pleasure to have known Tony as a colleague and close friend. He is sorely missed by all who knew him and we wish to dedicate this series of papers to his memory. We will not forget Tonys contribution to our research endeavours.
Export Options
About this article
Cite this article as:
Dedication to Professor Tony Dodi, Current Cancer Therapy Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339408784310106
DOI https://dx.doi.org/10.2174/157339408784310106 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Modulating Mitochondria-Mediated Apoptotic Cell Death through Targeting of Bcl-2 Family Proteins
Recent Patents on DNA & Gene Sequences What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary?
Current Women`s Health Reviews New Antitumour Natural Products from Marine Red Algae: Covering the Period from 2003 to 2012
Mini-Reviews in Medicinal Chemistry Common and Uncommon Features of Rheumatoid Arthritis and Chronic Obstructive Pulmonary Disease: Clues to a Future Therapy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate
Current Cancer Drug Targets Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay
Current Drug Targets Pro-apoptotic Activity of BH3-only Proteins and BH3 Mimetics: from Theory to Potential Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes
Current Gene Therapy The Acute Phase Protein α1-Acid Glycoprotein: A Model for Altered Glycosylation During Diseases
Current Protein & Peptide Science HPLC-NMR Chemical Profiling of the Australian Carnivorous Plant, Drosera erythrohiza subspecies magna
The Natural Products Journal Hydroxy Cinnamic Acid Derivatives as Partial PPARγ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562)
Anti-Cancer Agents in Medicinal Chemistry Withdrawal Notice: Recent Developments in Anti-Cancer Activity of Compounds Containing the Thioether Group
Anti-Cancer Agents in Medicinal Chemistry Cytosine Methyltransferases as Tumor Markers
Current Genomics Spirocyclic Nucleosides in Medicinal Chemistry: An Overview
Mini-Reviews in Medicinal Chemistry Specificity of Binding in Protein Kinases
Current Enzyme Inhibition Pleiotropic Effect of Mahanine and Girinimbine Analogs: Anticancer Mechanism and its Therapeutic Versatility
Anti-Cancer Agents in Medicinal Chemistry Identification of Drug Candidates for Breast Cancer Therapy Through Scaffold Repurposing: A Brief Review
Current Drug Research Reviews miRNAs Highlights in Stem and Cancer Cells
Mini-Reviews in Medicinal Chemistry Targeting the Hedgehog Pathway: The development of Cyclopamine and the Development of Anti-Cancer Drugs Targeting the Hedgehog Pathway
Mini-Reviews in Medicinal Chemistry Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies
Recent Patents on Anti-Cancer Drug Discovery